ALS News Today Forums Forums ALS Progress Research Topics Phases of Clinical Research – ALS treatments

  • bill1949

    September 28, 2021 at 4:52 pm

    These phases don’t even mention the phase of timing releases of information to investors. I believe phases are timed to maximize investors increasing the stock price of these development companies. A fast trial and weak results not too great for bottom line.

    • Amanda

      September 29, 2021 at 11:39 am

      You are right, it does not mention anything about investors because that wasn’t what I was searching for.

  • david-crellin

    October 6, 2021 at 9:46 am

    Interestingly the trial I’m about to start is a Phase 1b/2a first-in-human trial. Progress & dosing regimen in Phase 2b is dependent on safety & efficacy results from Phase 1b. Some participants will skip Phase 1b.

    For better or worse, as the first participant I’m a sentinel. I have more intensive monitoring, but also a greater chance of placebo. Why?????

Log in to reply.